1013238--3/31/2006--ARADIGM

related topics

{product, candidate, development}

{product, liability, claim}

{customer, product, revenue}

{product, market, service}

{property, intellectual, protect}

{personnel, key, retain}

{control, financial, internal}

{stock, price, share}

We have a history of losses and anticipate future losses. We may not be able to develop our products successfully. We may not be able to commercialize products successfully. We depend on collaborative partners and need additional collaborative partners. We have limited manufacturing experience. We rely on a small number of vendors and contract manufacturers to supply us with specialized equipment, tools and components. We depend upon proprietary technology and the status of patents and proprietary technology is uncertain. We may not obtain regulatory approval for our products on a timely basis, or at all. The results of preclinical and clinical testing are uncertain. We are in a highly competitive market and our competitors may develop alternative therapies. We depend on key personnel and must continue to attract and retain key employees. We may be exposed to product liability. Third-party reimbursement for our products is uncertain. Our stock price is likely to remain volatile.

Full 10-K form ▸

1013238--3/31/2006--ARADIGM_CORP